FIS reports Q1 2026 earnings on May 6 with short sellers adding positions steadily and analysts focused squarely on whether margin recovery can justify a stock still trading 30% below where it started the year.
Short interest has climbed about 11% over the past two weeks, reaching 2.8% of the free float. That figure is modest in absolute terms, but the directional shift is clear. Borrow conditions remain extremely easy — cost to borrow is just 0.39%, near its lowest level in months, and availability is wide open. The lending market is not tight, meaning short sellers face no friction building positions. Options positioning is mildly cautious but not alarmed. The put/call ratio is 0.51, a fraction above its 20-day average of 0.49 and well short of any elevated reading by historical standards. The stock itself has drifted flat over the past month at $46.54, recovering 1.8% on the week after a soft April.
The analyst community frames the debate around EBITDA margins. Bulls point to management's guidance for roughly 150 basis points of year-over-year margin expansion in the second half, supported by a rebound in banking activity and capital markets volumes. Bears counter that margin delivery has disappointed before and that structural headwinds — banking consolidation, acquisition integration, macro softness — make the recovery path fragile. Truist cut its target to $50 on April 24, the most recent move, while bulls like UBS and RBC hold targets in the $69-$73 range. The mean analyst target is $64.95, implying nearly 40% upside from here — a gap that underlines just how far the stock has to travel to close the discount. The forward EPS growth score ranks in the 92nd percentile, which is a genuine bull data point. The EPS surprise percentile, at 34, is less impressive and signals the company has a mixed track record on delivering versus expectations.
One notable signal pre-print: CEO Stephanie Ferris bought $1 million of stock on March 5 at $50.39, a price above where the stock trades now. The purchase registered as a meaningful open-market buy. It stands as the clearest signal from inside the company that management sees value at current levels, but the stock has since drifted below that entry.
The May 6 print will test whether the EBITDA margin trajectory is genuinely inflecting, or whether the cautious consensus — Hold ratings, trimmed targets, and a stock still deeply in the red for 2026 — is the more accurate read of where the business stands.
See the live data behind this article on ORTEX.
Open FIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
